NPJ Vaccines·Apr 11Influenza vaccine-specific CD4⁺ T cell responses are impaired in older adultsCohort study in peopleImmune responsePaper
Immunity & Ageing·Aug 24Advanced biological age is associated with improved antibody responses in older high-dose influenza vaccine recipients over four consecutive seasonsStudy of 292 peopleInfluenzaPaper
Immunity & Ageing·May 27Markers of systemic inflammation are positively associated with influenza vaccine antibody responses with a possible role for ILT2(+)CD57(+) NK-cellsStudy of 612 peopleImmune responsePaper
Frontiers in Aging·Feb 8Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older AdultsRandomized trial in 582 peopleInfluenzaPaper
Antiviral Research·Dec 22Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged miceExperiments in miceInfluenzaPaper
Aging·Dec 22The impact of physical frailty on the response to inactivated influenza vaccine in older adultsStudy in peopleMechanismsPaper
Vaccine·Dec 10Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in miceExperiments in miceInterventionsPaper
Open Forum Infectious Diseases·Jun 6Frailty Is Associated With Increased Hemagglutination-Inhibition Titers in a 4-Year Randomized Trial Comparing Standard- and High-Dose Influenza VaccinationTrial in peopleInterventionsPaper
The Brazilian Journal of Infectious Diseases·Dec 3Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in BrazilTrial in peopleInterventionsPaper